Skopos Labs, Inc. Collegium Pharmaceutical, Inc Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Skopos Labs, Inc. holds 529 shares of COLL stock, worth $15,266. This represents 0.0% of its overall portfolio holdings.
Number of Shares
529
Previous 82
545.12%
Holding current value
$15,266
Previous $2,000
650.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding COLL
# of Institutions
255Shares Held
37.2MCall Options Held
61.1KPut Options Held
5.8K-
Black Rock Inc. New York, NY5.79MShares$167 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3MShares$86.6 Million2.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$76.2 Million1.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$64.8 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.63MShares$47.1 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $985M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...